Division of Pulmonology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Division of Respirology, The Hospital for Sick Children, Toronto, ON, USA.
J Neuromuscul Dis. 2023;10(6):1075-1082. doi: 10.3233/JND-230053.
Chronic respiratory failure is a common endpoint in the loss of respiratory muscle function in patients with progressive neuromuscular disease (NMD). Identifying the onset of hypoventilation is critical to allow for the timely introduction of ventilator support and effectively manage respiratory failure [1-3]. While there are accepted criteria governing the diagnosis of hypoventilation during polysomnography (PSG) [4], there is concern that criteria are insufficient for identifying hypoventilation in the earlier stages of respiratory insufficiency related to NMD. The purpose of this project was to identify more sensitive criteria for identifying hypoventilation.
Fifteen pediatric pulmonologists with broad experience in managing patients with NMD, 10 of whom were board certified in and practice sleep medicine, were assembled and performed a review of the pertinent literature and a two-round Delphi process with 6 domains (Table 1).
Within the 6 domains there were three pertinent items per domain (Table 2). There was clear agreement on findings on history (morning headaches) and pulmonary function testing (FVC < 50% or awake TcCO2 > 45 mmHg) indicating a high concern for nocturnal hypoventilation. There was close agreement on the definitions for nocturnal hypercapnia and hypoxemia. PSG criteria were identified that indicate a patient is likely in the transitional phase from adequate ventilation to hypoventilation.
We identified a set of clinical criteria that may allow for more sensitive diagnosis of hypoventilation in NMD and earlier initiation of non-invasive ventilation leading to a reduction in the respiratory morbidity in progressive NMD. These criteria need to be further and more broadly validated prospectively to confirm their utility.
确定更敏感的呼吸肌功能障碍(RMD)患者发生通气不足的诊断标准。
召集了 15 名在诊治神经肌肉疾病(NMD)患者方面经验丰富的儿科肺病专家,其中 10 名具有睡眠医学专业认证并从事睡眠医学专业。这些专家对相关文献进行了回顾,并进行了两轮德尔菲法调查,共涉及 6 个领域(表 1)。
在这 6 个领域中,每个领域都有 3 个相关项目(表 2)。专家组对病史(晨起头痛)和肺功能检查(FVC<50%或清醒时 TcCO2>45mmHg)提示存在夜间通气不足的高度关注,以及对夜间高碳酸血症和低氧血症的定义达成了明确的共识。专家组还确定了提示患者可能处于从充分通气到通气不足的过渡阶段的 PSG 标准。
我们确定了一组临床标准,可能可以更敏感地诊断 NMD 患者的通气不足,并更早地开始无创通气,从而降低进行性 NMD 的呼吸发病率。这些标准需要进一步更广泛地前瞻性验证,以确认其效用。